BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  BPGbio Wins 2023 BioTech Breakthrough Award for Therapeutics Platform of The Year

  BPGbio Wins 2023 BioTech Breakthrough Award for Therapeutics Platform of The Year.

  November 8, 2023

   · 

  6 min read
• Silence Therapeutics to Present at Jefferies London Healthcare Conference - November 8, 2023

  Silence Therapeutics plc today announced that Craig Tooman, Silence President and CEO, will present a corporate update at the Jefferies London Healthcare Conference on Wednesday, November 15th at 4:30 p.m. GMT.

  November 8, 2023

   · 

  1 min read
• Business

  Charles River Laboratories Announces Third-Quarter 2023 Results

  Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2023.

  November 8, 2023

   · 

  29 min read
• Business

  Promega Named a BioSpace 2024 Best Places to Work Winner

  Promega Corporation has been named a BioSpace 2024 Best Place to Work.

  November 8, 2023

   · 

  2 min read
• Drug Development

  Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy

  Alterity Therapeutics today announced it has successfully completed enrolment in its ATH434-201 Phase 2 clinical trial.

  November 8, 2023

   · 

  6 min read
• Pharm Country

  Arbutus to Present at Jefferies London Healthcare Conference - November 8, 2023

  Arbutus Biopharma Corporation today announced that the Arbutus management team will participate in and host one-on-one meetings at the following investor conference.

  November 8, 2023

   · 

  1 min read
• Business

  Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

  Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended September 30, 2023.

  November 8, 2023

   · 

  49 min read
• Business

  Better Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023

  Better Therapeutics, Inc. today announced it will release its third quarter 2023 financial results before the market opens on Thursday, November 09, 2023.

  November 8, 2023

   · 

  1 min read
• Business

  ImmPACT Bio Recognized in BioSpace’s 2024 Best Places to Work

  ImmPACT Bio USA , Inc. today announced it has been named on the BioSpace 2024 Best Places to Work small employer list.

  November 8, 2023

   · 

  2 min read
• Business

  Crescita Reports Third Quarter 2023 Results

  Crescita Therapeutics Inc. today reported its financial results for the third quarter ended September 30, 2023 (“Q3-2023”).

  November 8, 2023

   · 

  15 min read